Cargando…
Current Evidence for Stereotactic Body Radiotherapy in Lung Metastases
Lung metastases are the second most common malignant neoplasms of the lung. It is estimated that 20–54% of cancer patients have lung metastases at some point during their disease course, and at least 50% of cancer-related deaths occur at this stage. Lung metastases are widely accepted to be oligomet...
Autores principales: | Gutiérrez, Enrique, Sánchez, Irving, Díaz, Omar, Valles, Adrián, Balderrama, Ricardo, Fuentes, Jesús, Lara, Brenda, Olimón, Cipatli, Ruiz, Víctor, Rodríguez, José, Bayardo, Luis H., Chan, Matthew, Villafuerte, Conrad J., Padayachee, Jerusha, Sun, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293144/ https://www.ncbi.nlm.nih.gov/pubmed/34287274 http://dx.doi.org/10.3390/curroncol28040233 |
Ejemplares similares
-
Stereotactic radiosurgery and stereotactic radiotherapy for brain metastases
por: Halasz, Lia M., et al.
Publicado: (2013) -
MLTI-06. Surgical resection plus stereotactic radiosurgery versus SRS alone for large brain metastases: a comparative study
por: Gutierrez, Enrique, et al.
Publicado: (2021) -
Dosimetric comparison of MR-guided adaptive IMRT versus 3DOF-VMAT for prostate stereotactic radiotherapy
por: Kong, Vickie C., et al.
Publicado: (2022) -
Solitary Extramedullary Plasmacytoma of the Head and Neck: A Report of Three Cases Treated With Curative Radiotherapy and a Review of the Dose-Control Relationship
por: Sanchez, Irving, et al.
Publicado: (2023) -
Impact of intrafraction changes in delivered dose of the day for prostate cancer patients treated with stereotactic body radiotherapy via MR-Linac
por: Dang, Jennifer, et al.
Publicado: (2022)